title: Of Marfan's syndrome, mice, and medications.
authors.affiliation: From the Divisions of Primary Care Internal Medicine (J.M.B.) and Cardiovascular Diseases (J.M.B., H.M.C.), Mayo Clinic, Rochester, MN.
authors.forename: Juan M
authors.initials: JM
authors.lastname: Bowen
authors.forename: Heidi M
authors.initials: HM
authors.lastname: Connolly
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001011:Aorta / Q000187:drug effects*; D001014:Aortic Aneurysm / Q000517:prevention & control*; D001262:Atenolol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008382:Marfan Syndrome / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D001262:Atenolol; D019808:Losartan